Form 4 Guardant Health, Inc. For: May 22 Filed by: Freeman Chris

Go back to Form 4 Guardant Health, Inc. For: May 22 Filed by: Freeman Chris

Guardant Health (GH) PT Raised to $160 at BTIG, Second Day in a Row

May 27, 2026 12:49 PM EDT

BTIG analyst Mark Massaro raised the price target on Guardant Health (NASDAQ: GH) to $160.00 (from $155.00) while maintaining a Buy rating.

Street Insider note: BTIG raised the PT yesterday to $155.00 from $145.00.

The analyst comments "This morning, the American Cancer Society (ACS), a... More